Literature DB >> 15278290

[Bioptic diagnosis of chronic hepatitis. Results of an evidence-based consensus conference of the German Society of Pathology, of the German Society for Digestive and Metabolic Diseases and of Compensated Hepatitis (HepNet)].

P Schirmacher1, W E Fleig, A Tannapfel, C Langner, V Dries, L Terracciano, H Denk, H P Dienes.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15278290     DOI： 10.1007/s00292-004-0692-7

Source DB:  PubMed          Journal:  Pathologe        ISSN： 0172-8113            Impact factor:   1.011


× No keyword cloud information.
  28 in total

1.  Perspectives on rapid paracentesis: positional and pressure effects.

Authors:  M E Gordon
Journal:  Gastroenterology       Date:  1991-06       Impact factor: 22.682

Review 2.  Classification of chronic viral hepatitis: a need for reassessment.

Authors:  P J Scheuer
Journal:  J Hepatol       Date:  1991-11       Impact factor: 25.083

3.  A 21-year experience with major hemorrhage after percutaneous liver biopsy.

Authors:  D B McGill; J Rakela; A R Zinsmeister; B J Ott
Journal:  Gastroenterology       Date:  1990-11       Impact factor: 22.682

Review 4.  [The treatment of chronic viral hepatitis B/D and acute and chronic viral hepatitis C. The consensus of the German Society for Digestive and Metabolic Diseases].

Authors:  U Hopf; C Niederau; G Kleber; W E Fleig
Journal:  Z Gastroenterol       Date:  1997-11       Impact factor: 2.000

5.  Percutaneous liver biopsy complications in patients with chronic renal failure.

Authors:  M Ozdoğan; O Ozgür; S Boyacioğlu; M Coşkun; H Kart; S Ozdal; H Telatar
Journal:  Nephron       Date:  1996       Impact factor: 2.847

6.  International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.

Authors:  F Alvarez; P A Berg; F B Bianchi; L Bianchi; A K Burroughs; E L Cancado; R W Chapman; W G Cooksley; A J Czaja; V J Desmet; P T Donaldson; A L Eddleston; L Fainboim; J Heathcote; J C Homberg; J H Hoofnagle; S Kakumu; E L Krawitt; I R Mackay; R N MacSween; W C Maddrey; M P Manns; I G McFarlane; K H Meyer zum Büschenfelde; M Zeniya
Journal:  J Hepatol       Date:  1999-11       Impact factor: 25.083

Review 7.  Histological grading and staging of chronic hepatitis.

Authors:  K Ishak; A Baptista; L Bianchi; F Callea; J De Groote; F Gudat; H Denk; V Desmet; G Korb; R N MacSween
Journal:  J Hepatol       Date:  1995-06       Impact factor: 25.083

8.  The normal adult human liver biopsy: a quantitative reference standard.

Authors:  A R Crawford; X Z Lin; J M Crawford
Journal:  Hepatology       Date:  1998-08       Impact factor: 17.425

9.  A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens: comparison with morphometric studies.

Authors:  M Chevallier; S Guerret; P Chossegros; F Gerard; J A Grimaud
Journal:  Hepatology       Date:  1994-08       Impact factor: 17.425

10.  Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis.

Authors:  R G Knodell; K G Ishak; W C Black; T S Chen; R Craig; N Kaplowitz; T W Kiernan; J Wollman
Journal:  Hepatology       Date:  1981 Sep-Oct       Impact factor: 17.425
View more
  6 in total

1.  [4. Austrian consensus-statement for diagnosis and therapy of hepatitis B 2009].

Authors:  Markus Peck-Radosavljevic; Johann Deutsch; Peter Ferenci; Ivo Graziadei; Harald Hofer; Heidemarie Holzmann; Wolf-Dietrich Huber; Herman Laferl; Andreas Maieron; Rudolf Stauber; Wolfgang Vogel
Journal:  Wien Klin Wochenschr       Date:  2010-05-04       Impact factor: 1.704

Review 2.  The etiology, diagnosis and prevention of liver cirrhosis: part 1 of a series on liver cirrhosis.

Authors:  Johannes Wiegand; Thomas Berg
Journal:  Dtsch Arztebl Int       Date:  2013-02-08       Impact factor: 5.594

Review 3.  [Chronic liver diseases--new therapy. Are biopsies necessary?].

Authors:  A Tannapfel
Journal:  Pathologe       Date:  2013-11       Impact factor: 1.011

Review 4.  [Quality and quantity in hepatopathology. Diagnostic and clinically relevant grading for non-tumourous liver diseases].

Authors:  T Longerich; C Flechtenmacher; P Schirmacher
Journal:  Pathologe       Date:  2008-02       Impact factor: 1.011

Review 5.  [Liver biopsy at the intersection of clinical and pathological diagnosis].

Authors:  U Spengler; H-P Fischer
Journal:  Pathologe       Date:  2008-02       Impact factor: 1.011

6.  Performance and Utility of Transient Elastography and Non-Invasive Markers of Liver Fiibrosis in Patients with Autoimmune Hepatitis: A Single Centre Experience.

Authors:  Olympia E Anastasiou; Matthias Büchter; Hideo A Baba; Johannes Korth; Ali Canbay; Guido Gerken; Alisan Kahraman
Journal:  Hepat Mon       Date:  2016-10-31       Impact factor: 0.660
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.